
Kenvue Fights to Shield Brands Like Listerine and Tylenol Amid £112m Tariff Shock
American consumer healthcare company Kenvue is implementing new ways to circumvent a potential tariff-related impact of £112.71 million ($150 million) on their business following the recent results of its Q1 2025. The company, which recently became an …